Welcome to our dedicated page for Bio Green Med Solution SEC filings (Ticker: BGMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bio Green Med Solution, Inc. filings document the company's fire safety protection and distribution business, its completed shift from the former Cyclacel Pharmaceuticals biopharmaceutical operations, and its public-company governance. Regulatory reports include 8-K disclosures for quarterly and annual results, Regulation FD releases, material agreements, warrant exchanges, and preferred-stock dividend declarations.
The filing record also covers the company's common stock and 6% Convertible Exchangeable Preferred Stock, proxy materials for annual stockholder matters, Nasdaq listing-compliance matters involving the preferred stock, and corporate history items such as the acquisition of Fitters Sdn. Bhd., the liquidation of the former U.K. subsidiary, and the sale of Plogosertib.
FITTERS Diversified Berhad reported beneficial ownership of 699,158 shares of Bio Green Med Solution, Inc. That holding represents 19.99% of the company's common stock and is reported as held with sole voting and sole dispositive power over those shares. The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The filer is organized in Malaysia and provided Malaysian addresses for both the issuer's principal office and the filer.
FITTERS Diversified Berhad reported initial beneficial ownership of 699,158 shares of Bio Green Med Solution, Inc. (BGMS) common stock on a Form 3 filed after an exchange agreement dated May 6, 2025 that closed on September 12, 2025. The filing lists FITTERS as a director of the issuer and states the shares are held directly. The Form 3 is signed by Datuk Tan Chor How Christopher on September 16, 2025. No derivative securities, option grants, or additional terms are disclosed in the filing.